Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study

We investigated magnetic resonance imaging (MRI) criteria identifying residual tumours in patients with triple-negative and human epidermal growth factor receptor type 2-positive (HER2+) breast cancer following neoadjuvant chemotherapy. Retrospectively, 290 patients were included who had undergone n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yunju, Sim, Sung Hoon, Park, Boram, Chae, In Hye, Han, Jai Hong, Jung, So-Youn, Lee, Seeyoun, Kwon, Youngmi, Park, In Hae, Ko, Kyounglan, Lee, Chan Wha, Lee, Keun Seok, Kang, Han-Sung, Lee, Eun Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804856/
https://www.ncbi.nlm.nih.gov/pubmed/33436702
http://dx.doi.org/10.1038/s41598-020-79743-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804856/
https://www.ncbi.nlm.nih.gov/pubmed/33436702
http://dx.doi.org/10.1038/s41598-020-79743-8

Ejemplares similares